Companies / NeuroPace Inc

NeuroPace Inc

Nasdaq: NPCECIK 1528287MOUNTAIN VIEW, CAneuropace.com

Financials · FY2025

Revenue$99.99M
Net income$-21.46M
Total debt$59.01M
Cash$12.54M
Diluted EPS$-0.66
Shares outstanding34.3M

Ownership

34.3M shares outstanding · as of Aug 7, 2026
2.3%Insiders
Ownership
Insiders2.32%795,416
Institutions76.76%26,348,297
Public float20.92%7,180,561

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
1.75%599,534
Becker JoelCEOCHIEF EXECUTIVE OFFICER · Director
0.28%96,937
Morrell MarthaCHIEF MEDICAL OFFICER
0.14%47,283
Kumar RakhiDirector
0.06%19,160
Geiger UriDirector
0.04%14,858
Lacob JosephDirector
0.04%14,754
<0.01%2,890

Institutional holders 106

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 15, 2025Morrell Martha
Executive
SellCommon Stock$399.3K-25K
-33.35%
49,964
0.15% of shares
medium
Mar 3, 2026Becker Joel
CEO
OtherCommon Stock$69.5K-5K
-4.93%
96,937
0.28% of shares
low
Feb 20, 2026Morrell Martha
Executive
OtherCommon Stock$48.9K-3K
-4.33%
75,322
0.22% of shares
low
Mar 20, 2026Fischer Frank M
Director
GrantCommon Stock$23.7K+2K
+0.31%
595,177
1.73% of shares
low
Jun 19, 2026Fischer Frank M
Director
GrantCommon Stock$22.9K+1K
+0.25%
599,534
1.75% of shares
low
Mar 3, 2026Morrell Martha
Executive
OtherCommon Stock$18.5K-1K
-2.68%
48,624
0.14% of shares
low
Mar 24, 2026Morrell Martha
Executive
OtherCommon Stock$17.8K-1K
-2.76%
47,283
0.14% of shares
low
Feb 27, 2026Becker Joel
CEO
OtherCommon Stock$16.4K-1K
-1.09%
101,960
0.30% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Orbimed Advisors LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NPCE641288105